| December 2005 · Vol. 17, No. 12 UPDATE on URINARY INCONTINENCE
New Developments That are Changing Patient Care
URINARY INCONTINENCE
Things go better with Burch…3 more drugs for overactive bladder…First-line OAB therapy for elderly women…Urethral injection of muscle-derived cells
|
Fast Track
Women with advanced prolapse who had abdominal sacrocolpopexy and Burch had superior benefits
Behavioral methods are first-line therapy for elderly women with overactive bladder, because the elderly are at high risk for drug interactions
|
|
Anne
M.
Weber,
MDAssociate Professor,
Department of Obstetrics,
Gynecology, and Reproductive Sciences,
University of Pittsburgh School of Medicine,
Magee-Womens Hospital,
Pittsburgh
Although urinary incontinence is one of the most common chronic diseases in women, we still don’t understand its pathophysiology, and treatments have been, of necessity, empiric rather than directed at a specific cause. Fortunately, this bleak scenario may be changing, and I think that is the most exciting news about urinary incontinence in 2005.
|
